Senores Pharmaceuticals Ltd vs Divis Laboratories Ltd
Side-by-side stock comparison based on AI earnings call analysis
Which stock has stronger management signals?
Senores Pharmaceuticals Ltd currently has the stronger revenue growth signal.
Senores Pharmaceuticals Ltd and Divis Laboratories Ltd show active capex signals based on earnings call analysis.
No strong fundraising signal is currently visible for either company.
| Metric | Senores Pharmaceuticals Ltd | Divis Laboratories Ltd |
|---|---|---|
| Current Price | ₹1,355 | ₹8,585 |
| Market Cap | ₹4,837.24 Cr. | ₹1.78 L Cr. |
| Industry | Pharmaceuticals & Biotechnology | Pharmaceuticals & Biotechnology |
| P/E Ratio | 41.93 | 70.32 |
| ROE (%) | 13.42 | 15.35 |
| Debt/Equity | 0.37 | 0.01 |
| Sales Growth 5Y (%) | — | 11.65 |
| Profit Growth 5Y (%) | 161.59 | 1.47 |
| Promoter Holding (%) | 9.62 | 19.13 |
| Revenue Rank | Rank 1 | Rank 3 |
| Margin Rank | Rank 3 | Rank 3 |
| Signal | — | — |
| Capex | Yes | Yes |
| Fundraise | No information | No information |